Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology III > Pain I - Opioids > Flashcards

Pain I - Opioids Flashcards

1
Q

What is pain?

A

An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage (from the International Association for the Study of Pain - IASP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is nociception?

A

The physiological process in response to a noxious stimulus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is allodynia?

A

Pain in resposne to a normally innocuous stimulus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is hyperalgesia?

A

Enhanced pain to a normally painful stimulus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List three major types of pain

A

Nociceptive: Direct activation of nociceptors by noxious stimuli

Inflammatory: Inflammatory mediators

Neuropathic: Nerve damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

True or false? There is safe and effective treatment for chronic pain sufferers.

A

False

There is still no safe and effective treatment for chronic pain sufferers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the steps in the pain pathway from nociceptor to brain

A
  • Nociceptor
  • Primary afferent
  • Dorsal root ganglion (cell body)
  • Second order neuron in spinal cord
  • Ascending processes to brain
  • Brain: affective behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List the steps in the pathway of normal movement, from mechanosensors to brain

A
  • Mechanosensor
  • Primary afferent
  • Dorsal root ganglion
  • Second order neurone in spinal cord
  • Ascending processes to brain
  • Brain: movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give a brief (2 events) history of opioids

A

3400 BC: Opium poppy is cultivated in lower Mesopotamia. Sumerians refer to it as Hul Gil, the joy plant.

1806: Sertüner isolated morphine (named after Morpheus, god of dreams)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define opiates and opioids

A

Opiates
- Drugs derived from opium

Opioids

  • Agents with opiate-like actions
  • Synthetic drugs
  • Proteins that mimic opiate actions (endorphins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define narcotics.

A

A drug or other substance affecting mood or behavior and sold for nonmedical purposes, especially an illegal one.

Drugs that pharmacologically induce sleep and produce dependence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the four opioid receptor subtypes and their effect on neurons. List an endogenous ligand for each.

A

Inhibit depolarization

  • μ: endomorphin
  • δ: enkephalin
  • κ: dynorphin

Depolarize neurons
- NOP: nociceptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe how opioid receptors can provide novel modulation by interacting with other receptors.

A

Opioid receptors can dimerize.

For example, the μ receptor can dimerize with cannabinoid receptor, CB1 and cause novel modulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the synthetic opioids for each opioid receptor.

A

μ: morphine, codeine, heroin
δ: diprenorphine
κ: etorphine
NOP: orphanin FQ (1-11)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the antagonists for the four opioid receptors, and one non-specific antagonist.

A

μ: CTOP, DAMGO
δ: naltrindole
κ: nor-BNI
NOP: nocistatin

Naloxone is a non-specific antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the action of opioids after a painful stimulus at a tissue level and a cellular level.

A
  • Opioids are released from macrophages, mast cells and leukocytes near sensory endings in the dermis.
  • Opioids sensitize peripheral nerves and reduce release of algogenic agents
  • μ receptors in lamina II of dorsal horn

Pre-synaptically

  • Excitatory NT release is inhibited
  • Calcium influx is inhibited

Post-synaptically
- Potassium influx increases (hyperpolarization)

17
Q

List the sites of action for opioids response to nociception

A
  1. The periphery (where stimuli occurs)
  2. MOR in lamina II of dorsal horn
  3. Supraspinal/brain (periaqueductal grey, insular cortex, dorsal raphe nuclei, nucleus raphe magnus
    - Activates descending inhibitory pathways (spinal release of 5-HT and NE)
    - Receptors close to respiratory centres give rise to respiratory depression
  4. Mesolimbic system (VTA, Nucleus accumbens, amygdala,)
    - Reward, euphoria, alters emotional response to pain
18
Q

What are the most common therapeutic indications for opioids?

A
  • Cancer pain
  • Primary option for acute pain
  • Reduced efficacy in chronic pain and increased risk of adverse effects
  • Therapeutic use requires continuous assessment
19
Q

Acute inflammation leads to the upregulation of what opioid receptor?

A

Upregulation of μ-opioid receptors at sensory nerve endings (periphery) and dorsal root ganglion. There is also upregulated axonal transport along the primary afferent.

All of this increases opioid analgesia in response to inflammation.

20
Q

Why do opioids lose their effect for chronic pain?

A

During acute inflammation there is upregulation of opioid receptors and opioid analgesia is very effective. But during chronic inflammation, there is marked downregulation of opioid receptors and opioid analgesia is not very effective at all.

21
Q

Give give main side effects of opioids

A
  • Severe constipation
  • Somnolescence
  • Cardiorespiratory depression
  • Tolerance
  • Dependence (addiction)
22
Q

Opioid use can lead to tolerance. Describe tolerance and the ways in which it can be minimized and treated.

A

Tolerance: increasing doses required to achieve therapeutic level. This occurs 2-3 weeks after starting opioid use.

It can be minimized by a low starting dose and a slow progression of dose

Treatment

  • Rotation to another opioid
  • Recoupling to a non-opioid adjunct (eg. ketamine)
23
Q

Give the mechanism for opioid tolerance

A

Desensitization and trafficking is mediated by GRKs (G protein coupled receptor kinases)

  • After arrestin binding, the receptor is desensitized at the surface. Then the receptors are internalized.
  • They can be recycled or degraded in a lysosome.
24
Q

Describe dependence associated with opioid use. Describe treatment.

A

Drug withdrawal produces physical abstinence syndrome:

Mild: lacrimation (flow of tears), sweating, yawning

Severe: Anorexia, cramps, nausea, vomiting, restlessness, irritability, tremor, HR/BP changes, chills and spasms. There is also PAIN.

Treatment

  • Cessation of drug intake
  • Naltrexone (μ-antagonist)
  • Methadone (μ-agonist - good oral availability (no more injections), selective, long-lasting/slow withdrawal.
25
Q

What is psychological dependence to opioids?

A

Compulsive drug seeking behaviour. This is seen with any drug that enhances mood by activating dopaminergic circuits.

26
Q

Describe opioid addiction and risk factors for it.

A

A state of physical and psychological dependence; preoccupation with acquiring and using drugs despite knowledge of adverse health effects; occurs to detriment of other activities.

Risk factors:

  • History of substance abuse
  • Mental illness
  • Addictive personality
27
Q

What is paradoxical opioid induced hyperalgesia?

A

Prolonged opioid use leading to increased pain

  • Sensitization of peripheral nociceptors
  • Sensitization of dorsal horn neurones
  • Altered descending control mechanisms. Glutamate receptor involvement; therefore co- administer glutamate antagonist
28
Q

Describe three interactions that opioids have with other drugs.

A
  • μ-opioid receptor dimerize with CB1 so that cannabinoids and opioids have a synergistic effect
  • Opioids plus low dose amphetamine offsets sedation.
  • Opioids and antidepressants can be useful together for neuropathic pain
29
Q

What is in the future for opioid analgesia?

A
  • Peripherally restricted opioids (eg. DIPOA). This is to target pain at the source and reduce sensitization of nociceptors. Also, not crossing the BBB would reduce addiction issues and other side effects (eg. resp depression)
  • Improving opioid receptor levels. Perhaps by inhibiting β-arrestin activity, inhibiting receptor degradation and/or promoting receptor recycling.

Pharmacology III (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions